Skip to content
Screener

Opko Health OPK Operating Income

Operating Income at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$459M+4.8%
Regenxbio logo
RegenxbioRGNX
$29.26M+146%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$11.89M-7.0%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$75M+30.6%
PTH
Pelthos TherapeuticsPTHS
-$13.09M-614%
Exelixis logo
ExelixisEXEL
$248.41M+16.3%

Segments

By segment

See full
Diagnostics$4.76M+126%
Pharmaceutical$839K+103%

Other financials

Income statement

See full
Revenue$163.6M+4.3%
Gross profit$80.0M+62.0%
Net income-$8.4M+94.3%
EPS (diluted)-$0.01+94.7%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$49.9M-7.5%
Total equity$1.2B-8.7%
Total assets$1.8B-7.3%

Cash flow

See full
Operating cash flow-$43.5M+47.9%
CapEx$3.0M-8.5%
Free cash flow-$46.5M+46.4%

Valuation

See full
Market cap$985.15M-2.3%
P/S1.7×+0.2×

Profitability

See full
Gross margin40.8%+8.1pp
Operating margin-8.2%-3.5pp
Net margin-12.4%-4.3pp
FCF margin-22.8%-6.7pp

Returns & leverage

See full
Return on equity-5.9%-2.1pp
Debt / equity0.0×
Current ratio3.3×-0.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Opko Health’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-318090
Line itemFor the three months ended June 30, 2026For the three months ended June 30, 2025For the six months ended June 30, 2026For the six months ended June 30, 2025
Amortization of intangible assets18,96919,44437,93539,304
Gain on sale of assets(18,070)(18,070)
Total costs and expenses170,552216,788345,764433,907
Operating loss(6,972)(59,981)(57,987)(127,148)
Other income (expense), net:
Interest income3,2213,2876,2287,968
Interest expense(11,380)(70,327)(22,319)(85,794)
Fair value changes of derivative instruments, net(65)16(363)(257)

Item 1. Financial Statements

FAQ

What is Opko Health's operating income?
Opko Health (OPK) reported operating income of -$6.97M in Q2 2026.
How has Opko Health's operating income changed year-over-year?
Opko Health's operating income increased by 88.4% year-over-year, from -$59.98M to -$6.97M.
What is the long-term trend for Opko Health's operating income?
Over 2 years (2022 to 2025), Opko Health's operating income has grown at a -28.0% compound annual growth rate (CAGR), from -$226.25M to -$117.41M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about Opko Health's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude